ArticleClinical pharmacology and therapeutics2026

Safety, Pharmacokinetics, and Dose Recommendations for Nirmatrelvir/Ritonavir in Individuals with Mild to Moderate COVID-19 and Severe Renal Impairment.

Jacqueline Gerhart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.